<DOC>
	<DOCNO>NCT01892228</DOCNO>
	<brief_summary>The aim study measure effectiveness pilot program Guangxi , China decrease mortality relate HIV . The study 's propose mechanism decrease mortality rate shorten time initial HIV screen ART implementation within two week . The study population consist participant receive initial HIV infection diagnosis within study period . Medical institution provide `` one-stop service '' follow detailed guideline regard report positive HIV antibody screening , test procedure , treatment referral accordance pre-determined timetable . In addition , additional strategy focus policy development , medical personnel training , broad general public education campaign implement . Main assessment measure HIV-related mortality rate , treatment coverage , health outcome .</brief_summary>
	<brief_title>Pilot Study Immediate HIV Treatment Guangxi , China</brief_title>
	<detailed_description>The aim study measure effectiveness pilot program Guangxi , China decrease mortality related HIV/AIDS . In past year , Guangxi experience relatively high rate late HIV diagnosis , contribute significant proportion HIV-related death occur year initial diagnosis . The study 's propose mechanism decrease mortality rate shorten time initial HIV screen ART implementation within two week . Two pilot site select base past core assessment indicator . The study population consist participant receive initial HIV infection diagnosis within study period . Medical institution provide `` one-stop service '' follow detailed guideline regard report positive HIV antibody screening , test procedure , treatment referral accordance pre-determined timetable . In addition , additional strategy focus policy development , medical personnel training , broad general public education campaign implement . The study perform July,2012 July,2015 . Main assessment measure HIV-related mortality rate , treatment coverage , health outcome . 1 . HIV-related mortality rate participant newly diagnose study period Numerator : Number all-cause death study period Denominator : Number HIV infect patient follow study period . 2 . Percentage newly diagnose HIV-infected participant receive ART Numerator : Number patient diagnose HIV initiate ART study period Denominator : Number newly report HIV case study period</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>New diagnosis HIV infection define positive HIV antibody screen result July 1 , 2012 July 1 , 2015 OR Having current residential address inside pilot site limit Exclusion criterion : Current reside outside border designate study site</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>antiretroviral therapy</keyword>
	<keyword>education</keyword>
	<keyword>mortality</keyword>
</DOC>